Intravenous γ-globulin therapy in bronchial asthma

Allergy and Asthma Proceedings

Volumn 23, Issue 1, 2002, Pages 15-18

  Schwartz, Howard J ^a,b   Berger, Melvin ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBIN; IMMUNOGLOBULIN;

ASTHMA; HUMAN; REVIEW;

ASTHMA; GLOBINS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS;

EID: 0036358435     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mazer B, and Gelfand E. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma J Allergy Clin Immunol 87:976-983, 1991.
2. Landwehr LP, Jeppsen JD, Katlan MG, et al. Benefits of high-dose IV immunoglobulin in patients with severe steroid-dependent asthma. Chest 114:1349-1356, 1998.
3. Salmun LM, Barlan I, Wolf HM, et al Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled randomized trial. J Allergy Clin Immunol 103:810-815, 1999.
4. Gelfand EW, Landwehr LP, Esterl B, et al. Intravenous immune globulin: an alternative therapy in steroid-dependent allergic diseases. Clin Exp Immunol 104(suppl 1):61-66, 1996.
5. Anderssen JP, and Anderssen WG. Human intravenous immnoglobulin modulates monokine production in-vitro. Immunology 71:372-376, 1990.
6. Amran D, Renz H, Lack G, et al. Suppression of cytokine dependent human T-cell proliferation by intravenous immunoglobulin. Clin Immunol Immunopathol 73:180-186, 1994.
7. Modliano JF, Amran D, Lack G, et al. Post transcriptional regulation of T-cell IL-2 production by human pooled immunoglobulin. Clin Immunol Immunopathol 83:75-88, 1997
8. Spahn JD, Leung DY, Chan MT, et al. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin. J Allergy Clin Immunol 103:421-426, 1999.
9. Sigman K, Ghibu F, Sommerville W, et al. Intravenous immunoglobulin inhibits IgE production in human B lymphocytes. J Allergy Clin Immunol 102:421-427, 1998.
10. Tuffaha A, Gern JE, and Lcmanske RF. The role of respiratory viruses in acute and chronic asthma. Clin Chest Med 21:289-300, 2000.
11. Gern JE. Viral and bacterial infection in the development and progression of asthma J Allergy Clin Immunol 105:5497-5502, 2000.
12. Kraft M. The role of bacterial infections in asthma. Clin Chest Med 21:301-313, 2000.
13. Chang KC, Vollmer WM, Barrett MJ, et al. Prolonged episodes of persistent asthma: A distinct clinical pattern with characteristic clinical features. Chest 117:944-949, 2000.
14. Welliver RC, Wong DJ, Middleton E, Jr. et al. Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr 101 889, 1982
15. Lemanske RF, Dick EC, Swanson CA, et al. Rhinovirus upper respiratory infection increases airway hype/reactivity and late asthmatic responses. J Clin Invest 83:1-10, 1989.
16. Schwartz HJ, Thompson JS, Sher TH. et al Occult sinus abnormalities in the asthmatic patient. Arch Intern Med 147:2194-2196, 1987.
17. Mings R, Friedman WH, Slavin RG, et al. Five year follow-up of the effects of bilateral intra-nasal sphenoethmoidectomy in patients with sinusitis and asthma. Am J Rhinol 71:123-127, 1988.
18. Shapiro GG, Virant FS, Furukawa CJ, et al. Immunologic defects in patients with refractory sinusitis. Pediatrics 88:1074-1075, 1991.
19. Page R, Friday G, Stillwagon P, et al. Asthma and selective immunoglobulin subclass deficiency: improvement of asthma after immunoglobulin replacement therapy. J Pediatr 112:127-131, 1998.
20. Berger M, Clark H, Hostoffer R, et al. IVIG replacement therapy in asthmatics with mild hypogammaglobulmemia. J Allergy Clin Immunol 95:315, 1995 (Abs).
21. Leung DY Steroid-resistant asthma; IVIG may be an effective alternative J Respir Dis 21:162-163, 2000.